Video: Boosting the efficacy and reducing the toxicity of the chemotherapy drug methotrexate

Cancer cells decorate themselves with the CD47 protein, signaling the immune system to stand down. Whitehead Institute Valhalla Fellow Kipp Weiskopf and colleagues have developed a novel drug screen, pinpointing which cancer therapies — when combined with CD47-blocking antibodies — fare best at rallying the immune system against lung cancer cells.

Sunny Das is a postdoc in Whitehead Institute Member Robert Weinberg’s lab studying how breast cancer metastasizes or spreads to other tissues. We sat down with Sunny to learn more about him and his experiences in and out of the lab.

Eric Smith is a postdoc in Whitehead Institute Member Iain Cheeseman’s lab studying proteins involved in cancer. We sat down with Eric to learn more about him and his experiences in and out of the lab.